Feedback
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
CORRECT!
Faculty & Disclosures
Dr Tristan Barber
Royal Free London NHS Foundation Trust,
London, UK
Tristan Barber is a consultant physician in HIV medicine at the Ian Charleson Day Centre, Royal Free Hospital and honorary associate professor at the Institute for Global Health, University College London. read more
Dr Barber is chair of the European AIDS Clinical Society Young Investigators, honorary secretary and chair of the Education and Scientific Subcommittee for the British HIV Association and chair of the Board of Trustees for the peer support charity Positively UK.Â
Dr Barber established a dedicated frailty service for ageing patients with HIV infection in 2019 (The Sage Clinic). He has a research background in HIV-related neurocognitive impairment and antiretroviral clinical trials. Dr Barber is the current editor-in-chief of HIV Research and Clinical Practice.
Dr Tristan Barber discloses: Advisory board or panel fees from Gilead Sciences, Janssen, MSD and ViiV Healthcare. Consultancy fees from Gilead Sciences, Janssen, MSD and ViiV Healthcare. Grants/research support from Gilead Sciences, Roche and ViiV Healthcare. Speaker’s bureau fees from Gilead Sciences, Janssen, MSD and ViiV Healthcare.
Dr Christoph Boesecke
University of Bonn,
Bonn, Germany
Christoph Boesecke is an infectious diseases specialist and senior lecturer at the University of Bonn, Germany. read more
Dr Boesecke completed his medical studies at Charité University in Berlin, Germany. He received his doctorate in medicine from the University of Hamburg, Germany, for his research in acute HIV infection. He held a 2-year postgraduate position studying integrase inhibitors in acute and chronic HIV infection at the National Centre in HIV Epidemiology and Clinical Research (now The Kirby Institute) in Sydney, Australia.
His main areas of research are comorbidities and coinfections in people living with HIV, including COVID19 and monkeypox.
Dr Christoph Boesecke discloses: Advisory board or panel fees from AbbVie, Gilead Sciences, Johnson & Johnson, MSD, Pfizer and ViiV Healthcare. Consultant fees from AbbVie, Gilead Sciences, Johnson & Johnson, MSD, Pfizer and ViiV Healthcare. Grants/research support from DZIF, Hector Foundation, NEAT ID. Speaker’s bureau fees from AbbVie, AstraZeneca, Bavarian Nordic, Gilead Sciences, Johnson & Johnson, MSD, Pfizer and ViiV Healthcare.
